[Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].

Yan, Q; Yao, W T; Du, X H; Guo, L Y; Fan, Y C

Yan, Q; Yao, W T; Du, X H; Guo, L Y; Fan, Y C.

Afiliação

Yan Q; Department of Bone and Soft Tumor, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450003, China.
Yao WT; Department of Bone and Soft Tumor, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450003, China.
Du XH; Department of Bone and Soft Tumor, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450003, China.
Guo LY; Department of Bone and Soft Tumor, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450003, China.
Fan YC; Department of Bone and Soft Tumor, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450003, China.

Zhonghua Zhong Liu Za Zhi ; 45(10): 904-910, 2023 Oct 23.

Article em Zh | MEDLINE | ID: mdl-37875427

Assuntos

Neoplasias Ósseas; Síndrome Mão-Pé; Sarcoma Sinovial; Sarcoma; Neoplasias de Tecidos Moles; Humanos; Estudos Retrospectivos; Sarcoma/tratamento farmacológico; Sarcoma Sinovial/tratamento farmacológico

Palavras-chave

Anlotinib; Efficacy; Osteosarcoma; Safety; Soft tissue sarcoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Neoplasias Ósseas / Sarcoma Sinovial / Síndrome Mão-Pé Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google